Zurich and Further Group in May 2025 announced they would offer a new employee benefit – called Critical Care – designed to help those needing treatment for serious illnesses. Critical Care can provide life-changing well-being benefits for employees who have cancer, heart or neurological conditions, are in need of organ transplants, or require specialist treatment abroad at leading hospitals. It can be added to any Zurich International Group Life

G20 merchandise trade increased in Q1 2025 with exports and imports rising by 2.0% and 3.1%, respectively, compared with Q4 2024; the latest statistics show a mixed picture in services, with exports decreasing by 0.7% and imports increasing by 1.0%.

According to the Organization for Economic Cooperation and Development (OECD), its provisional estimates released in May 2025 show that gross domestic product (GDP) across the OECD area rose by just 0.1 % quarter-on-quarter in the first quarter (Q1) 2025, down markedly from 0.5 % in the previous quarter. This breaks the pattern of relatively strong and stable growth seen in the OECD area over the past two years. G7

Unum joins Generali Employee Benefits Network as its new employee benefits partner in the UK market for Group Risk products. Generali UK branch transfers the renewal rights of its employee benefits (Group Risk) business to Unum and its employee benefits team is to be welcomed to Unum.

MAXIS Global Benefits Network (MAXIS GBN) in April 2025 announced that it will be enhancing its MAXIS Global Pool Solution. Its updated solution, designed to support multinational employers at every stage of their pooling journey, includes a multi-employer pool (MEP) methodology, complementing its single-employer pool (SEP) offering. Under this new model, smaller MAXIS pool programmes will become part of the MEP, transitioning to a SEP if and when their

MAXIS Global Benefits Network in April 2025 released its 2025 whitepaper which looks in-depth at the growing impact of rising cancer rates on multinational employers and insurers. The whitepaper uses MAXIS GBN’s global claims data, drawn from standardized, anonymized data from millions of claimants around the world, to provide practical strategies for addressing claims trends. Cancer is a topic that has dominated discussions in the global health space in